APA

Bright S. A., Campiani G., Deininger M. W., Lawler M., Williams D. C. & Zisterer D. M. (20100520). Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. : Biochemical pharmacology.

Chicago

Bright Sandra A, Campiani Giuseppe, Deininger Michael W, Lawler Mark, Williams D Clive and Zisterer Daniela M. 20100520. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. : Biochemical pharmacology.

Harvard

Bright S. A., Campiani G., Deininger M. W., Lawler M., Williams D. C. and Zisterer D. M. (20100520). Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. : Biochemical pharmacology.

MLA

Bright Sandra A, Campiani Giuseppe, Deininger Michael W, Lawler Mark, Williams D Clive and Zisterer Daniela M. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. : Biochemical pharmacology. 20100520.